This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Galen V. Poole, MD; John A. Griswold, MD; Farid F. Muakkassa, MD
University of Mississippi Medical Center Jackson

JAMA. 1991;266(11):1511-1512.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.

—Pugin et al¹ reported that topical oropharyngeal decontamination with polymyxin B sulfate, neomycin sulfate, and vancomycin hydrochloride in patients requiring mechanical ventilation can greatly reduce the incidence of tracheobronchial colonization and pneumonia compared with a placebo administered in the same fashion. This is the latest in a series of studies that have demonstrated uniformly that the frequency of pneumonias acquired in the intensive care unit can be reduced by oropharyngeal, gastric, and occasionally, systemic antibiotics.

This study has also added further confirmation to a growing body of evidence that while many critically ill patients die with pneumonia, they do not necessarily die from pneumonia. Despite a fivefold reduction in the risk of pneumonia in patients receiving oropharyngeal antibiotics, Pugin et al found no difference in the hospital mortality between patients who received oropharyngeal antibiotics and those who received oropharyngeal placebos. Similar data, with different antibiotic regimens, . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?